Journal profile · Medicine-Pharmacology (medical)
Geneesmiddelenbulletin
ISSN 0304-4629 · eISSN 2589-1782 · Stichting Geneesmiddelenbulletin
Geneesmiddelenbulletin: subscription journal; 65 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Geneesmiddelenbulletin is published by Stichting Geneesmiddelenbulletin. By OpenAlex counts of its recent articles, its largest topics are Diabetes Treatment and Management, SARS-CoV-2 and COVID-19 Research and Pharmacovigilance and Adverse Drug Reactions, together about 23.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Stichting Geneesmiddelenbulletin (Ge-Bu) is dé onafhankelijke bron voor rationele farmacotherapie, voor en door zorgverleners. Onze onafhankelijke plaatsbepalingen zijn gebaseerd op kritisch onderzoek en volledig vrij van commerciële invloeden.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Pharmacology (medical)
Main research topics OpenAlex counts of recent articles; shares are approximate
- Diabetes Treatment and ManagementMedicine8.1%
- SARS-CoV-2 and COVID-19 ResearchMedicine7.6%
- Pharmacovigilance and Adverse Drug ReactionsPharmacology, Toxicology and Pharmaceutics7.6%
- COVID-19 Clinical Research StudiesMedicine5.6%
- Lipoproteins and Cardiovascular HealthMedicine5%
- Antiplatelet Therapy and Cardiovascular DiseasesMedicine4.5%
- Heart Failure Treatment and ManagementMedicine4.2%
- Diabetes Management and ResearchMedicine4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Pharmacology (medical) | Q4 | 251/275 | 8th |
| Pharmacology | Q4 | 296/321 | 7th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
ISSN: 2589-1782Publisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 0.3LetPub ·
- SJR 2026-06
- 0.11LetPub ·
- SNIP 2026-06
- 0LetPub ·
- h-index
- 2OpenAlex ·
- i10-index
- 1OpenAlex ·
- 2-year mean citedness
- 0.04OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 329 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 24 | 6 | 1 |
| 2025 | 65 | 46 | 5 |
| 2024 | 42 | 33 | 5 |
| 2023 | 39 | 23 | 9 |
| 2022 | 44 | 0 | 4 |
| 2021 | 47 | 0 | 4 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted2
- review29 augustus 2026 Review Nieuw geneesmiddel: Seladelpar bij primaire biliaire cholangitisLength not stated
- update19 maart 2024 Update Update: Profylaxe RS-virusinfecties bij pasgeborenenLength not stated
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Stichting Geneesmiddelenbulletin
- ISSN
- 0304-4629
- Electronic ISSN
- 2589-1782
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Geneesmiddelenbulletin
Which databases index Geneesmiddelenbulletin?
According to LetPub and DOAJ records, Geneesmiddelenbulletin is indexed in Scopus.
Is Geneesmiddelenbulletin open access, and what is the APC?
Geneesmiddelenbulletin is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .